Exagen will pay Cypress up to $8 million in upfront and milestone payments as well as additional royalty payments for the business.
Under the deal, Marina will receive $750,000 up front, and stands to be paid as much as $27 million in milestones.
The firm offers its Avise PG test as a service for physicians making decisions about methotrexate therapy.
Cypress will pay up to $5 million for the technology, which it plans to use for diagnosis and therapeutic monitoring of lupus patients.
Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.
The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.
The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.
In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.